Research Research Areas Research Groups Selected Publications Selected Projects Open Science
Laboratories Core Facilities Booking system Industry 4.0 Testbed Industry Cooperation
Education PhD School Postdoc Programme Seminar Series CEITEC Student Talent Internships
Career Training Jobs HRS4R Award Alumni Network Welcome Office Innovation Accelerator
About Us News Events People Organisational Structure Scientific Evaluation To Download Press and Media Contacts
CZ
Home Research Selected Publications Combination of fludarabine, amsacrine, and cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with high-risk acute myeloid leukemia Research Research Areas Medical Genomics
Share Share Share

Combination of fludarabine, amsacrine, and cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with high-risk acute myeloid leukemia

ANNALS OF HEMATOLOGY

Krejci, M; Doubek, M; Dusek, J; Brychtova, Y; Racil, Z; Navratil, M; Tomiska, M; Horky, O; Pospisilova, S; Mayer, J, 2013: Combination of fludarabine, amsacrine, and cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with high-risk acute myeloid leukemia. ANNALS OF HEMATOLOGY 92(10), p. 1397 - 1403, doi: 10.1007/s00277-013-1790-5

CEITEC authors: